泛免疫炎症值在心血管疾病中的研究进展  

Pan-Immune-Inflammation Value and Cardiovascular Diseases

作　　者：谢朋昌 侯经远 钟志雄 XIE Pengchang;HOU Jingyuan;ZHONG Zhixiong(Guangdong Medical University,Zhanjiang 524023,Guangdong,China;Meizhou People’s Hospital(Meizhou Academy of Medical Sciences),Meizhou 514031,Guangdong,China)

机构地区：[1]广东医科大学,广东湛江524023 [2]梅州市人民医院(梅州市医学科学院),广东梅州514031

出　　处：《心血管病学进展》2025年第4期341-345,共5页Advances in Cardiovascular Diseases

基　　金：广东省基础与应用基础研究基金(2022A1515012590)。

摘　　要：心血管疾病因其日益攀升的发病率和致死率,已经成为全球范围内的重大公共卫生问题。免疫和炎症反应在心血管疾病的病理进程中发挥着关键作用。近年来,随着免疫炎症生物标志物的不断发现,其在临床实践和科学研究中的应用引起了广泛关注。不断积累的证据表明,泛免疫炎症值在心血管疾病、肿瘤以及脑血管疾病等多个领域中,展现出了显著的诊断价值和预后风险评估潜力。现系统探讨泛免疫炎症值在心血管疾病研究中的应用现状及其在临床实践中的潜在意义,旨在为后续的研究提供参考。Cardiovascular diseases(CVD)have become a major public health problem worldwide due to their increasing morbidity and mortality.In the occurrence and development of CVD,immune and inflammatory responses play a key role in the pathological process.In recent years,with the discovery of immunoinflammatory biomarkers,their application in clinical practice and scientific research has attracted wide attention.Accumulating evidence indicates that the pan-immune-inflammation value(PIV)demonstrates significant diagnostic value and potential for risk assessment of prognosis in CVD,oncology,and cerebrovascular diseases.This review systematically explores the current application of PIV in cardiovascular disease research and its potential significance in clinical practice,aiming to provide a reference for subsequent studies.

关 键 词：泛免疫炎症值 心血管疾病 生物标志物 诊断 预后 

分 类 号：R54[医药卫生—心血管疾病]